ESR1 and breast cancer: The potential benefit of these detailed annotations is clear: While finding a suitable set of samples across studies was virtually impossible using existing unstructured information alone, we are now able to easily find and compare, for example, 4,405 breast cancer samples with 473 normal breast samples, or 2052 ER+ versus 284 ER- samples.